Abstract
VLDL largely inhibited the action of nicotinic acid in lowering basal glycerol release. As VLDL is a large macromolecule it is unlikely to cross the fat cell membrane. Thus the site of its action on the antilipolytic action of nicotinic acid is likely to be at the cell membrane rather than within the fat cell.